Hester Biosciences consolidated net profit rises 100.49% in the September 2024 quarter
Net profit of Hester Biosciences rose 100.49% to Rs 8.20 crore in the quarter ended September 2024 as against Rs 4.09 crore during the previous quarter ended September 2023. Sales rose 18.78% to Rs 83.69 crore in the quarter ended September 2024 as against Rs 70.46 crore during the previous quarter ended September 2023.
Particulars | Quarter Ended | ||
Sep. 2024 | Sep. 2023 | % Var. | |
Sales | 83.69 | 70.46 | 19 |
OPM % | 22.89 | 18.75 | - |
PBDT | 16.07 | 11.05 | 45 |
PBT | 11.87 | 6.76 | 76 |
NP | 8.20 | 4.09 | 100 |

Low Price Shares
0 mins read . Dec 18, 2024

Nifty 50 Top 10 Stocks
0 mins read . Dec 18, 2024

Best Stocks in 2025
0 mins read . Dec 18, 2024

Explore our products
Unlimited Trading starting at ₹249
Open Trading Account